Motus GI Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 12, 2021 08:00 ET
|
Motus GI Holdings, Inc.
Reported approximately 40% increase in revenue compared to Q2 2021On track to file a 510(k) submission to FDA by end of 2021 for Pure-Vu EVS, an advanced, next-generation system that will enhance...
Motus GI to Release Third Quarter Results and Provide a Business Update on November 12
October 28, 2021 16:05 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI Announces Presentation of Results from Independent Study of Pure-Vu System in IBP Patients at the 2021 ACG Annual Scientific Meeting
October 26, 2021 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that...
Motus GI Announces the Passing of Independent Director Dr. Sam Nussbaum
September 28, 2021 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) ("Motus GI" or the "Company") announced with profound sadness that Samuel R. Nussbaum, MD, an...
Motus GI to Present at the Oppenheimer & Co. Inc. Fall Healthcare Summit
September 13, 2021 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that...
Motus GI Announces Enrollment of Patients at Second Site in the European Union Outpatient Study of the Pure-Vu® System
September 08, 2021 08:05 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI to Participate in Two Upcoming Investor Conferences in September 2021
September 07, 2021 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that...
Motus GI Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 12, 2021 16:05 ET
|
Motus GI Holdings, Inc.
Reported a 95% revenue increase versus Q1 2021; the fourth consecutive quarter of revenue growth Received FDA clearance for Pure-Vu sleeve for Upper GI endoscopies and initiated pilot patient cases...
Motus GI to Release Second Quarter Results and Provide a Business Update on August 12
July 29, 2021 16:05 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., July 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI Secures Expanded $12M Credit Financing to Support Growth Strategy
July 21, 2021 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., July 21, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...